Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Current Vascular Pharmacology
|
October 5, 2016
Gender Disparity in Lipid Target Achievements in High and Very High Atherosclerotic Cardiovascular Disease Risk Patients in the Arabian Gulf
Ibrahim Al-Zakwani, Abdullah Shehab, Ali T Al-Hinai, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 26, 2023
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
The Lancet. Diabetes & Endocrinology
|
June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raul D Santos, Samuel S Gidding, Robert A Hegele, et al.
Journal of Clinical Lipidology
|
April 9, 2016
Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf
Khamis Al-Hashmi, Ibrahim Al-Zakwani, Wael Al Mahmeed, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 14, 2023
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Current Vascular Pharmacology
|
October 27, 2015
Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf
Ibrahim Al-Zakwani, Wael Al-Mahmeed, Mohamed Arafah, et al.
Expert Opinion on Drug Safety
|
April 25, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Archives of Medical Science : AMS
|
April 11, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Atherosclerosis
|
September 27, 2015
Familial hypercholesterolaemia: A global call to arms
Antonio J Vallejo-Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, et al.
Cardiovascular Diabetology
|
June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Jean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Current Vascular Pharmacology
|
October 5, 2016
Gender Disparity in Lipid Target Achievements in High and Very High Atherosclerotic Cardiovascular Disease Risk Patients in the Arabian Gulf
Ibrahim Al-Zakwani, Abdullah Shehab, Ali T Al-Hinai, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 26, 2023
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
The Lancet. Diabetes & Endocrinology
|
June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raul D Santos, Samuel S Gidding, Robert A Hegele, et al.
Journal of Clinical Lipidology
|
April 9, 2016
Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf
Khamis Al-Hashmi, Ibrahim Al-Zakwani, Wael Al Mahmeed, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 14, 2023
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Current Vascular Pharmacology
|
October 27, 2015
Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf
Ibrahim Al-Zakwani, Wael Al-Mahmeed, Mohamed Arafah, et al.
Expert Opinion on Drug Safety
|
April 25, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Archives of Medical Science : AMS
|
April 11, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Atherosclerosis
|
September 27, 2015
Familial hypercholesterolaemia: A global call to arms
Antonio J Vallejo-Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, et al.
Cardiovascular Diabetology
|
June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Jean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Page
of 15